Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians
Jian Chen1, Haya Ascher-Svanum1, Allen W Nyhuis1, Michael G Case1, Glenn A Phillips1, Kory J Schuh1, Vicki Poole Hoffmann2 1Eli Lilly and Company, 2Lilly USA, LLC, Indianapolis, IN, USA Background: The aim of this study was to assess the reasons for discontinuing or continuing olanzapine in patients...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-11-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/reasons-for-continuing-or-discontinuing-olanzapine-in-the-treatment-of-a8592 |